EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Integrative analyses of bulk and single-cell RNA-seq reveals the correlation between SPP1+ macrophages and resistance to neoadjuvant chemoimmunotherapy in esophageal squamous cell carcinoma

Zhenyang Geng, Feng Li, Zhichang Yang, Bowen Li, Yifan Xu, Bin Wu, Yinliang Sheng, Ping Yuan, Lan Huang, Yu Qi

Cancer Immunology, Immunotherapy · 05.10.2024 · 73 (12)

DOI: 10.1007/s00262-024-03848-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, online erschienen am 05.10.2024. Verfasst von Zhenyang Geng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Hauptthemen laut MEDLINE: Neoadjuvant Therapy, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Macrophages. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Health Commission of Henan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neoadjuvant chemoimmunotherapy (NACI) has significant implications for the treatment of esophageal cancer. However, its clinical efficacy varies considerably among patients, necessitating further investigation into the underlying mechanisms. The rapid advancement of single-cell RNA sequencing (scRNA-seq) technology facilitates the analysis of patient heterogeneity at the cellular level, particularly regarding treatment outcomes. In this study, we first analyzed scRNA-seq data of esophageal squamous cell carcinoma (ESCC) following NACI, obtained from the Gene Expression Omnibus (GEO) database. After performing dimensionality reduction, clustering, and annotation on the scRNA-seq data, we employed CellChat to investigate differences in cell-cell communication among samples from distinct efficacy groups. The results indicated that macrophages in the non-responder exhibited stronger cell communication intensity compared to those in responders, with SPP1 and GALECTIN signals showing the most significant differences between the two groups. This finding underscores the crucial role of macrophages in the efficacy of NACI. Subsequently, reclustering of macrophages revealed that Mac-SPP1 may be primarily responsible for treatment resistance, while Mac-C1QC appears to promote T cell activation. Finally, we conducted transcriptome sequencing on ESCC tissues obtained from 32 patients who underwent surgery following NACI. Utilizing CIBERSORT, CIBERSORTx, and WGCNA, we analyzed the heterogeneity of tumor microenvironment among different efficacy groups and validated the correlation between SPP1+ macrophages and resistance to NACI in ESCC using publicly available transcriptome sequencing datasets. These findings suggest that SPP1+ macrophages may represent a key factor contributing to resistance against NACI in ESCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoadjuvant TherapyEsophageal Squamous Cell CarcinomaEsophageal NeoplasmsMacrophagesSingle-Cell AnalysisRNA-SeqDrug Resistance, NeoplasmImmunotherapyHumansOsteopontinTumor MicroenvironmentMaleFemaleBiomarkers, TumorSingle-Cell Gene Expression Analysis

Stichwörter der Autor:innen

Bulk RNA sequencingEsophageal squamous cell carcinomaMacrophagesNeoadjuvant chemoimmunotherapySingle-cell RNA sequencing

Substanzen

OsteopontinBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Thoracic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Translational Medicine Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. lanhuang@zzu.edu.cn.
  • Department of Thoracic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. qiyu_zzu@126.com.

Förderung

  • Health Commission of Henan Province

Zitieren

APA

Geng, Z., Li, F., Yang, Z., Li, B., Xu, Y., Wu, B., Sheng, Y., Yuan, P., Huang, L., & Qi, Y. (2024). Integrative analyses of bulk and single-cell RNA-seq reveals the correlation between SPP1+ macrophages and resistance to neoadjuvant chemoimmunotherapy in esophageal squamous cell carcinoma. Cancer Immunology, Immunotherapy, 73(12). https://doi.org/10.1007/s00262-024-03848-6

Vancouver

Geng Z, Li F, Yang Z, Li B, Xu Y, Wu B, et al. Integrative analyses of bulk and single-cell RNA-seq reveals the correlation between SPP1+ macrophages and resistance to neoadjuvant chemoimmunotherapy in esophageal squamous cell carcinoma. Cancer Immunology, Immunotherapy. 2024;73(12). doi:10.1007/s00262-024-03848-6

BibTeX
@article{Geng2024,
  author = {Geng, Zhenyang and Li, Feng and Yang, Zhichang and Li, Bowen and Xu, Yifan and Wu, Bin and Sheng, Yinliang and Yuan, Ping and Huang, Lan and Qi, Yu},
  title = {Integrative analyses of bulk and single-cell RNA-seq reveals the correlation between SPP1+ macrophages and resistance to neoadjuvant chemoimmunotherapy in esophageal squamous cell carcinoma},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2024},
  volume = {73},
  number = {12},
  doi = {10.1007/s00262-024-03848-6}
}
Kostenlos starten →